Hunter C. Smith, Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 60,840 shares at $84.50 ($4.8M) on 2025-07-09, disclosed to the SEC on 2025-07-11.
Scheduled sale ($4.8M) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $75.38 | 17,113 | $1.3M | 26.9% |
| 2 | $75.38 | 17,113 | $1.3M | 26.9% |
| 3 | $76.17 | 1,607 | $122K | 2.5% |
| 4 | $76.17 | 1,607 | $122K | 2.5% |
| 5 | $84.50 | 23,400 | $2.0M | 41.2% |
| Total | $78.93 avg | 60,840 |
| $4.8M |
| 100% |
| Filing → |
| RYTM | SELL | 2026-02-12 | $1.2M | — | Filing → |
| RYTM | SELL | 2026-02-06 | $1.4M | — | Filing → |
| RYTM | SELL | 2025-08-14 | $5.1M | — | Filing → |